January
PR company appoints new UK head
Chamberlain Healthcare Public Relations has appointed Mark John Cater as managing director of its London office
04 Jan 2010
Study shows pedometer reduces diabetes risk
Using a pedometer could reduce the chances of developing Type 2 diabetes by more than 50 per cent, according to a new study
04 Jan 2010
Cancer risk increases with blood sugar
Up to one in six Britons with high blood-sugar levels faces a greater danger of developing cancer, according to new research
04 Jan 2010
Novartis to take over Alcon eye-care co.
Novartis has announced plans to buy the remaining 77 per cent stake in eye-care company Alcon, paying $38.5bn
04 Jan 2010
Communiqué – stepping into Europe…
The new format Communiqué is now available throughout Europe. Your feedback will be invaluable in helping us to evaluate just how well Communiqué meets your needs
05 Jan 2010
Nanoparticles could deliver medication
Researchers in the US have created nanosized particles that can penetrate the body's mucus secretions to deliver a sustained-release medication
05 Jan 2010
Step forward in cancer research
Scientists have found some 'junk DNA' sequences have important roles in the genome that could help diagnose breast and bowel cancer
06 Jan 2010
Merz acquire BioForm Medical
Merz Pharma have agreed to acquire BioForm Medical for $253m, expanding its presence in cosmetic pharmaceuticals
06 Jan 2010
Andrew Witty appointed president of EFPIA
The European Federation of Pharmaceutical Industries and Associations has appointed Andrew Witty, CEO of GlaxoSmithKline, as its new president
07 Jan 2010
Swedish prescription safety programme
International partnership provides national drug utilisation review programme for Swedish pharmacies to improve prescription safety
07 Jan 2010